Protara Therapeutics Ownership | Who Owns Protara Therapeutics?
Protara Therapeutics Ownership Summary
Protara Therapeutics is owned by 76.15% institutional investors, 2.21% insiders, and 21.64% retail investors. Janus henderson group is the largest institutional shareholder, holding 11.31% of TARA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.01% of its assets in Protara Therapeutics shares.
TARA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Protara Therapeutics | 76.15% | 2.21% | 21.64% |
| Sector | Healthcare Stocks | 128.69% | 12.02% | -40.72% |
| Industry | Biotech Stocks | 180.58% | 11.62% | -92.20% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Janus henderson group | 5.21M | 11.31% | $27.15M |
| Millennium management | 3.10M | 7.24% | $11.85M |
| Boxer capital | 811.63K | 7.11% | $1.69M |
| Velan capital investment management lp | 2.84M | 6.64% | $10.87M |
| Blackrock funding, inc. /de | 3.71M | 6.07% | $11.30M |
| Vanguard group | 2.39M | 5.66% | $12.75M |
| Blackstone | 2.27M | 5.29% | $8.65M |
| Orbimed advisors | 2.22M | 5.18% | $8.48M |
| Sio capital management | 1.92M | 4.49% | $7.34M |
| Acorn capital advisors | 1.75M | 4.09% | $6.69M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Velan capital investment management lp | 2.84M | 6.62% | $10.87M |
| Acorn capital advisors | 1.75M | 1.83% | $6.69M |
| 5am venture management | 1.37M | 1.82% | $5.23M |
| Sio capital management | 1.92M | 1.21% | $7.34M |
| Verdad advisers, lp | 312.25K | 1.14% | $1.19M |
| Cvi | 302.75K | 0.54% | $629.71K |
| Catalio capital management, lp | 520.15K | 0.37% | $1.99M |
| Stempoint capital lp | 363.67K | 0.32% | $1.58M |
| Superstring capital management lp | 121.46K | 0.29% | $463.97K |
| Integral health asset management | 1.50M | 0.23% | $5.73M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Orbimed advisors | 2.22M | 0.16% | 2.22M |
| Balyasny asset management | 1.03M | 0.00% | 1.03M |
| Marshall wace, llp | 1.54M | 0.00% | 842.26K |
| Boxer capital | 811.63K | 0.09% | 602.40K |
| Vanguard group | 2.39M | 0.00% | 487.75K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Aigh capital management | - | - | -1.62M |
| Driehaus capital management | - | - | -1.26M |
| Adage capital partners gp | - | - | -1.04M |
| Ra capital management | - | - | -1.04M |
| Patient square capital lp | - | - | -1.03M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Orbimed advisors | 2.22M | 0.16% | 2.22M | $8.48M |
| Balyasny asset management | 1.03M | 0.00% | 1.03M | $3.92M |
| Verdad advisers, lp | 312.25K | 1.14% | 312.25K | $1.19M |
| Cvi | 302.75K | 0.54% | 302.75K | $629.71K |
| Jane street group | 291.49K | 0.00% | 291.49K | $889.05K |
Sold Out
| Holder | Change |
|---|---|
| Wealth preservation advisors | -1.00 |
| Ifp advisors | -2.00 |
| Clearstead advisors | -3.00 |
| Jpl wealth management | -4.00 |
| Root financial partners | -5.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | 114 | -7.32% | 46,458,321 | 0.47% | 76 | 1.33% | 61 | -23.75% | 36 | 33.33% |
| Jun 30, 2026 | 121 | 2.54% | 46,228,325 | 1.46% | 107 | 0.95% | 78 | 1.30% | 27 | 8.00% |
| Mar 31, 2026 | 112 | 4.67% | 43,683,816 | 9.71% | 94 | 1.07% | 72 | -4.00% | 24 | 50.00% |
| Dec 31, 2025 | 44 | -46.99% | 9,253,946 | -64.69% | 21 | 0.57% | 28 | -22.22% | 10 | -61.54% |
| Sep 30, 2025 | 33 | -59.26% | 6,687,978 | -77.49% | 15 | 0.32% | 18 | -65.38% | 8 | -38.46% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.66M | 3.01% | 116.30K |
| Vanguard Morn Total Stk Mkt Idx Investor | 1.66M | 3.01% | 116.30K |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.66M | 2.81% | - |
| iShares Russell 2000 ETF | 1.33M | 2.26% | - |
| Vanguard US Total Market Shares ETF | 616.30K | 1.74% | - |
| Columbia Small Cap Value Discv A | 768.47K | 1.30% | 5.60K |
| Biotech Growth Ord | 691.00K | 1.17% | 245.00K |
| Vanguard Institutional Extnd Mkt Idx Tr | 586.97K | 0.99% | - |
| Fidelity Small Cap Index | 569.27K | 0.96% | - |
| iShares Russell 2000 Value ETF | 514.10K | 0.87% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 29, 2026 | Shefferman Jesse | CEO and President | Sell | $882.16K |
| Apr 08, 2026 | Zummo Jacqueline | Chief R&D Officer | Sell | $6.12K |
| Apr 01, 2026 | Zummo Jacqueline | Chief R&D Officer | Sell | $118.87K |
| May 14, 2025 | Levy Richard S | - | Buy | $63.80K |
| Mar 26, 2025 | Zummo Jacqueline | Chf Scientific Operations Off | Sell | $96.14K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 3 |
| 2026 Q1 | - | - |
| 2025 Q2 | 1 | - |
| 2025 Q1 | - | 1 |
| 2024 Q3 | - | 18 |
TARA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools